Table 2 Comparison of clinical characteristics between the periods before and during COVID-19

Performance Status*

0/1

98 (91,6%)

106 (89,8%)

0,838^mc

2

6 (5,61%)

7 (5,93%)

3

3 (2,80%)

5 (4,24%)

Alcoholism*

Yes

34 (37,36%)

31 (27,68%)

0,187^f

No

57 (62,64%)

81 (72,32%)

Smoking*

Yes

20 (21,74%)

21 (18,75%)

0,723^f

No

72 (78,26%)

91 (81,25%)

Tumor location

Ileocecal junction

10 (9,26%)

12 (10,17%)

0,879^mc

Ascending colon

20 (18,52%)

23 (19,49%)

Hepatic flexure

5 (4,63%)

2 (1,69%)

Transverse colon

14 (12,96%)

13 (11,02%)

Splenic flexure

2 (1,85%)

1 (0,85%)

Descending colon

7 (6,48%)

9 (7,63%)

Sigmoide colon

50 (46,30%)

58 (49,15%)

Method of diagnosis

Emergency surgery

27 (25,0%)

30(25,40%)

0,939 ^q

Colonoscopy

81 (75,0%)

88 (74,60%)

Surgery

Radical

60 (55,60%)

73 (61,90%)

0,347^q

Palliative

48 (44,40%)

45 (38,10%)

Type of surgery*

Elective

49 (46,20%)

52 (44,40%)

0,893^q

Emergency

57 (53,80%)

65 (55,60%)

Protective ostomy

Yes

52 (48,10%)

44 (37,30%)

0,108^q

No

56 (51,90%)

74 (62,70%)

Stage

2

21 (19,4%)

16 (13,56%)

0,061^q

3

35 (32,4%)

57 (48,31%)

4

52 (48,2%)

45 (38,14%)

Systemic treatment

Adjuvant

58 (53,70%)

73 (61,86%)

0,269^f

Palliative

50 (46,30%)

45 (38,14%)

Length of stay at hospital

Median (SD)

6,94 (5,26)

7,33 (5,62)

0,715^mw

Readmission*

Yes

6 (5,90%)

6 (5,30%)

> 0,999^q

No

95 (94,10%)

107 (94,70%)

Post-surgery complication*

Yes

15 (14,70%)

15 (13,20%)

0,844^q

No

87 (85,30%)

99 (86,90%)

ICU stay*

Yes

43 (46,70%)

46 (44,20%)

> 0,775^q

No

49 (53,30%)

58 (55,80%)